These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37480572)

  • 1. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
    Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
    Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer.
    Liu D; Li C; Deng Z; Luo N; Li W; Hu W; Li X; Qiu Z; Chen J; Peng J
    Front Med (Lausanne); 2024; 11():1403171. PubMed ID: 39267963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer.
    Yi T; Zhang Y; Ng DM; Xi Y; Ye M; Cen L; Li J; Fan X; Li Y; Hu S; Rong H; Xie Y; Zhao G; Chen L; Chen C; Ni S; Mi J; Dai X; Liao Q
    Front Oncol; 2021; 11():685515. PubMed ID: 34211853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
    Jiang Y; Yan X; Liu K; Shi Y; Wang C; Hu J; Li Y; Wu Q; Xiang M; Zhao R
    BMC Cancer; 2020 Oct; 20(1):1012. PubMed ID: 33076847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multi-omics differences in left-side and right-side colon cancer.
    Huang Y; Duanmu J; Liu Y; Yan M; Li T; Jiang Q
    PeerJ; 2021; 9():e11433. PubMed ID: 34026368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer.
    Hu Y; Ding J; Wu C; Gao H; Ge M; Shao Q; Liu Y; Ye Q
    Front Oncol; 2022; 12():845765. PubMed ID: 35936748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer.
    Narayanan S; Gabriel E; Attwood K; Boland P; Nurkin S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e671-e678. PubMed ID: 30108021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.
    Wang QY; Zhong WT; Xiao Y; Lin GL; Lu JY; Xu L; Zhang GN; Du JF; Wu B
    World J Gastroenterol; 2024 Sep; 30(33):3823-3836. PubMed ID: 39351432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
    Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
    World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
    Lim DR; Kuk JK; Kim T; Shin EJ
    Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
    Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
    Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.
    Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG
    Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of circulating immune cells in left- and right-sided colon cancer.
    Di J; Zhuang M; Yang H; Jiang B; Wang Z; Su X
    PeerJ; 2017; 5():e4153. PubMed ID: 29230377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
    Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
    BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
    Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
    Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
    Lv S; Tao L; Liao H; Huang Z; Lu Y
    Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.